Predicting drug-related liver injury using blood tests and expert review
Part of Digestive system clinical trials.
This trial builds a prediction model to identify drug-related liver injury (DILI) by looking at your blood test patterns, timing, and expert diagnosis. It may help improve how doctors recognize this condition earlier and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your situation fits drug-related liver injury based on RUCAM scoring (a liver-injury checklist score).
- Your recent blood tests show liver inflammation or blockage patterns (ALT and/or ALP and/or bilirubin are above set cutoffs).
- The liver injury started within the last 3 months before you are enrolled.
- At least one of these applies: a specialist diagnosis vote supports DILI (if the RUCAM score is in the 3–5 range).
- You have not been diagnosed with certain other liver causes (like viral hepatitis or autoimmune hepatitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods (RUCAM and RECAM) to better identify what caused a recent liver injury. It may help doctors find the right cause and treatment faster.
This study follows people who developed liver injury from a medicine (not from other causes). It aims to better describe different types and severities of drug-related liver injury and may help improve how clinicians recognize and manage it.
This study puts people with a past drug- or herbal-related liver injury into a research registry. The goal is to better understand why the injury happens so doctors can prevent and recognize it sooner.
This trial tests whether steroids (glucocorticoids) can help people with acute liver injury caused by a drug, especially when bilirubin levels are high. It aims to see if steroids can reduce liver damage and improve recovery.
This trial tests whether plasmapheresis (a blood-cleaning procedure) can help people with severe drug-induced liver injury who also have a chronic liver condition. If you qualify, you would receive this treatment to try to reduce liver damage and improve recovery.
This study looks at itching caused by drug-induced liver injury. Researchers want to understand who gets itchy and how bad it is, which could help improve care for people with this condition.
Hear when a new Drug Induced Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.